The performance of multi‐biomarker DNA testing has long been validated, and several fecal DNA‐based markers such as SFRP2, NDRG4, SDC2, and TFPI2 have been recognized as potential biomarkers for CRC detection [63, 64, 65, 66]. This evidence concerns the gene SFRP2 and colorectal carcinoma.